BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37519563)

  • 21. Clinical and radiological features of severe acute respiratory syndrome coronavirus 2 meningo-encephalitis.
    de Freitas GR; Figueiredo MR; Vianna A; Brandão CO; Torres-Filho HM; Martins AFA; Tovar-Moll F; Barroso PF
    Eur J Neurol; 2021 Oct; 28(10):3530-3532. PubMed ID: 34524721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splenium of the Corpus Callosum Infarct Associated With COVID-19: Case Report.
    Karp DA; Beaudoin G; Egan RA
    Neurologist; 2023 Jul; 28(4):244-246. PubMed ID: 36044912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient blindness associated with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS): a case report and review of literature.
    Tuscano A; Zoppo M; Canavese C; Cogoni M; Scolfaro C
    Ital J Pediatr; 2020 Oct; 46(1):152. PubMed ID: 33046117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mild encephalitis/encephalopathy with a reversible splenial corpus callosum lesion (MERS)].
    Moreno-Caballero L; Navas-Campo R; Bello-Franco CM; Sesé-Lacámara L; Sáez-Valero E; Gimeno-Peribáñez MJ
    Rev Neurol; 2021 Sep; 73(6):219-222. PubMed ID: 34515335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical cytotoxic lesion and hemorrhagic involvement of the corpus callosum in severe COVID-19 infection.
    Guarnizo Capera AP; Gallo Tapias M; David Cardona Ortegón J; Ferrer Valencia V
    Curr Med Imaging; 2023 Apr; ():. PubMed ID: 37066778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible lesion in the splenium of the corpus callosum.
    Tetsuka S
    Brain Behav; 2019 Nov; 9(11):e01440. PubMed ID: 31588684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination.
    Takanashi J; Shiihara T; Hasegawa T; Takayanagi M; Hara M; Okumura A; Mizuguchi M
    J Neurol Sci; 2015 Feb; 349(1-2):226-8. PubMed ID: 25542078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-Restricted Lesions of the Splenium: Clinical Presentation, Radiographic Patterns, and Patient Outcomes.
    Stamm B; Lineback CM; Tang M; Jia DT; Chrenka E; Sorond F; Sabayan B
    Neurol Clin Pract; 2023 Oct; 13(5):e200196. PubMed ID: 37840827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with Mycoplasma pneumoniae infection.
    Yuan ZF; Shen J; Mao SS; Yu YL; Xu L; Jiang PF; Gao F; Xia ZZ
    BMC Infect Dis; 2016 May; 16():230. PubMed ID: 27230114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic lesions of the corpus callosum in children: Etiology, clinical and radiological features, and prognosis.
    Aksu Uzunhan T; Maraş Genç H; Kutlubay B; Kalın S; Bektaş G; Yapıcı Ö; Çıracı S; Sözen HG; Şevketoğlu E; Palabıyık F; Gör Z; Çakar NE; Kara B
    Brain Dev; 2021 Oct; 43(9):919-930. PubMed ID: 34120800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273.
    Ailsworth SM; Keshavarz B; Richards NE; Workman LJ; Murphy DD; Nelson MR; Platts-Mills TAE; Wilson JM
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):67-73. PubMed ID: 36241020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terminal ileitis and cytotoxic lesion of corpus callosum as the presenting features of Multisystem inflammatory syndrome in children (MIS-C): a case report.
    Davoodi M; Pouladfar G; Kadivar MR; Dehghan A; Askarisarvestani A; Hamzavi SS
    BMC Pediatr; 2023 Jan; 23(1):15. PubMed ID: 36627589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinically mild encephalitis/encephalopathy with a reversible splenial lesion of corpus callosum in a child and literature review].
    Zhao L; Wu Y; Guo M; Xiao J; Jiang Y
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):218-22. PubMed ID: 24824394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    Stowe J; Miller E; Andrews N; Whitaker HJ
    PLoS Med; 2023 Jun; 20(6):e1004245. PubMed ID: 37285378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome.
    Yang Q; Chang CC; Liu M; Yu YQ
    BMC Med Imaging; 2019 Apr; 19(1):35. PubMed ID: 31039748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult severe encephalitis/encephalopathy with a reversible splenial lesion of the corpus callosum: A case report.
    Mao XJ; Zhu BC; Yu TM; Yao G
    Medicine (Baltimore); 2018 Jun; 97(26):e11324. PubMed ID: 29953022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis.
    Ka A; Britton P; Troedson C; Webster R; Procopis P; Ging J; Chua YW; Buckmaster A; Wood N; Jones C; Dale RC
    Eur J Paediatr Neurol; 2015 May; 19(3):377-82. PubMed ID: 25707871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination.
    Hara M; Mizuochi T; Kawano G; Koike T; Shibuya I; Ohya T; Ohbu K; Nagai K; Nagamitsu S; Yamashita Y; Nakayama T; Matsuishi T
    Brain Dev; 2011 Nov; 33(10):842-4. PubMed ID: 21273018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.